Paper Details

  1. Home
  2. Paper Details

Comparative bronchodilatory activity of cetiedil citrate monohydrate, theophylline, orciprenaline and placebo in adult asthmatics.

Author: ChoY W, HanH C, KuemmerleH P, OhS Y

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Cetiedil, theophylline, and orciprenaline were all effective in improving wheezing scores in patients with asthma. Cetiedil was the most effective drug in blocking exercise-induced bronchospasm.
Paper Details　
Original Abstract of the Article :
In 40 patients, a seven day observation period in which oral bronchodilators and corticosteroids were eliminated, cetiedil (100 mg, t.i.d.), theophylline (200 mg, t.i.d.) or orciprenaline (20 mg, t.i.d.) and placebo (100 mg Lactose, t.i.d.) were given for one week each, according to a double blind, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/359494

データ提供：米国国立医学図書館（NLM）

Comparative Bronchodilatory Activity of Cetiedil Citrate Monohydrate, Theophylline, Orciprenaline and Placebo in Adult Asthmatics

The field of [asthma management] is constantly searching for more effective and safe treatment options. This study compares the bronchodilatory activity of [cetiedil, theophylline, orciprenaline, and placebo] in adult asthmatics. It aims to evaluate the relative effectiveness of these medications in relieving asthma symptoms and to identify any potential differences in their ability to prevent exercise-induced bronchospasm. This research is a valuable contribution to the understanding of asthma treatment, offering insights into the relative effectiveness of different bronchodilators.

Cetiedil: A Promising Bronchodilator for Asthma

The study reveals that cetiedil was the most effective drug in blocking exercise-induced bronchospasm. It also demonstrated significant improvements in both FEV1/VC and PEFR, suggesting its effectiveness in improving lung function at rest. These findings suggest that cetiedil may be a promising bronchodilator for asthma, particularly for individuals who experience exercise-induced bronchospasm.

Tailoring Treatment: Choosing the Right Bronchodilator

This study highlights the importance of individualizing asthma treatment. The findings suggest that different bronchodilators may have varying degrees of effectiveness for different patients. Understanding the specific needs and symptoms of each individual is crucial for selecting the most appropriate treatment strategy.

Dr.Camel's Conclusion

This study is like a desert wind, sweeping away the uncertainties surrounding asthma treatment. It compares the effectiveness of different bronchodilators, revealing the potential of cetiedil as a promising option for individuals with asthma. This research empowers clinicians to make informed decisions about asthma management, selecting the most appropriate treatment for each patient.

Date :
  1. Date Completed 1978-12-29
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

359494

DOI: Digital Object Identifier

359494

Related Literature

Article Analysis
・Side Effects of metaproterenol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.